New Enterprise Associates 15, L.P.'s Net Worth

$810 Million

Who is New Enterprise Associates 15, L.P.?

New Enterprise Associates 15, L.P. has an estimated net worth of $810 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., AVEO PHARMACEUTICALS, INC., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, and Achaogen Inc.

SEC CIK

New Enterprise Associates 15, L.P.'s CIK is 0001629794

Past Insider Trading and Trends

2018 was New Enterprise Associates 15, L.P.'s most active year for acquiring shares with 26 total transactions. New Enterprise Associates 15, L.P.'s most active month to acquire stocks was the month of July. 2021 was New Enterprise Associates 15, L.P.'s most active year for disposing of shares, totalling 22 transactions. New Enterprise Associates 15, L.P.'s most active month to dispose stocks was the month of July. 2021 saw New Enterprise Associates 15, L.P. paying a total of $87,118,710.00 for 208,338,857 shares, this is the most they've acquired in one year. In 2019 New Enterprise Associates 15, L.P. cashed out on 6,662,532 shares for a total of $169,894,566.00, their largest year based on trade value.